These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6722409)

  • 1. Structural requirements for activity of certain 'specific' antirheumatic drugs: more than a simple thiol group?
    Drury PL; Rudge SR; Perrett D
    Br J Rheumatol; 1984 May; 23(2):100-6. PubMed ID: 6722409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing property of some slow acting antirheumatic drugs.
    Huck F; de Médicis R; Lussier A; Dupuis G; Federlin P
    J Rheumatol; 1984 Oct; 11(5):605-9. PubMed ID: 6512791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of the disease-modifying anti-arthritic thiol agents D-penicillamine and sodium aurothiomalate: restoration of cellular free thiols and sequestration of reactive aldehydes.
    Wood PL; Khan MA; Moskal JR
    Eur J Pharmacol; 2008 Feb; 580(1-2):48-54. PubMed ID: 18022616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is gold necessary in so called chrysotherapy?
    Munthe E; Jellum E
    Scand J Rheumatol Suppl; 1983; 51():46-51. PubMed ID: 6426053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antirheumatic drugs on protein sulphydryl reactivity of human serum.
    Hall NC; Gillan AH
    J Pharm Pharmacol; 1979 Oct; 31(10):676-80. PubMed ID: 41040
    [No Abstract]   [Full Text] [Related]  

  • 6. On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum.
    Pickup ME; Dixon JS; Bird HA
    J Pharm Pharmacol; 1980 Apr; 32(4):301-2. PubMed ID: 6103066
    [No Abstract]   [Full Text] [Related]  

  • 7. Modes of action of second-line agents.
    Bacon PA; Salmon M
    Scand J Rheumatol Suppl; 1987; 64():17-24. PubMed ID: 3124265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
    Tsvetkova ES
    Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results?
    Menard HA; Mathieu JP; de Medicis R; Lussier A
    J Rheumatol; 1979; 6(2):156-62. PubMed ID: 110929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis.
    Ward JR
    Am J Med; 1988 Oct; 85(4A):39-44. PubMed ID: 3052055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigational agents for rheumatoid arthritis.
    Merkel PA; Letourneau EN; Polisson RP
    Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.
    Hurst NP; Bell AL; Nuki G
    Ann Rheum Dis; 1986 Jan; 45(1):37-43. PubMed ID: 3006610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
    Minami M; Kaneda K
    Ryumachi; 1995 Oct; 35(5):780-91. PubMed ID: 8594657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Other penicillamine-like drugs.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():180-1. PubMed ID: 6785437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1991 Jul; 33(848):65-70. PubMed ID: 1676134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 19. Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.
    Rudge SR; Perrett D; Swannell AJ
    Ann Rheum Dis; 1984 Oct; 43(5):698-702. PubMed ID: 6437348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues.
    Griem P; Takahashi K; Kalbacher H; Gleichmann E
    J Immunol; 1995 Aug; 155(3):1575-87. PubMed ID: 7543525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.